(2E)-2-(N-hydroxyimino)-N-phenylacetamide, 98%, 100mg

4-(Diethylamino)salicylaldehyde>98.0%(GC)(T)25g

4-Oxo-4H-chromene-2-carboxylic acid, 97.0%, 1g

2,3-Dimethoxynaphthalene, 95.0%, 100g

N~2~-methyl-N~2~-phenyl-1,2-propanediamine hydrochloride, 95.0%, 5g

1-(2,5-Difluoro-4-methoxyphenyl)ethanone, 97%, 100mg

1-tert-Butyl 3-methyl 5-oxopiperidine-1,3-dicarboxylate, 95.0%, 1g

6,6'-dihydroxy-5,5'-dimethoxybiphenyl-3,3'-dicarboxylic acid, 250mg

PUROMYCIN AMINONUCLEOSIDE, 95%, 250mg

6,7,8-trimethyl-1,2,3,4-tetrahydro-1,5-naphthyridine, 95.0%, 250mg

Dimethyl [1,1'-biphenyl]-4,4'-dicarboxylate, 95.0%, 1g

Methyl 2-chloroquinoline-3-carboxylate, 95.0%, 5g

3-Hydroxybenzaldehyd, min. 97 %, zur Synthese, 50 g, kunststoffverpackung.